Stockscreener 앱 받기
0.61
3.17%
-0.02
전일 마감가:
$0.63
열려 있는:
$0.617
하루 거래량:
53,290
Relative Volume:
0.04
시가총액:
$5.63M
수익:
-
순이익/손실:
$-8.26M
주가수익비율:
-0.0114
EPS:
-53.609
순현금흐름:
$-12.17M
1주 성능:
-11.04%
1개월 성능:
-23.56%
6개월 성능:
-22.59%
1년 성능:
-98.37%
1일 변동 폭
$0.6032
$0.6498
1주일 범위
$0.59
$0.675
52주 변동 폭
$0.3015
$63.57
Gri Bio Inc Stock (GRI) Company Profile
명칭
Gri Bio Inc
전화
(619) 400-1171
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
GRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
0.62 | 5.63M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.87 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.11 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
662.88 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.25 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.37 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | H.C. Wainwright | Buy |
Gri Bio Inc 주식(GRI)의 최신 뉴스
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire
IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register
Windtree Therapeutics Appoints Leanne Kelly to Board of Directors and Audit Committee - Defense World
Windtree Therapeutics Appoints Leanne Kelly to Board, Advances New Growth Strategy - MyChesCo
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - The Manila Times
Windtree Therapeutics Strengthens Board with Biotech Finance Veteran Leanne Kelly - StockTitan
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews
The GRI Marketing Group Joins SDL to Accelerate North America CX Growth Strategy - Yahoo Finance
Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Increases By 155.5% - Defense World
FLYHT Aerospace Solutions Ltd. (OTCMKTS:FLYLF) Sees Significant Growth in Short Interest - Defense World
Viracta stock falls on strategic review (VIRX:NASDAQ) - Seeking Alpha
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and - EIN News
GRI Bio Announces European Patent Office Issued a Decision - GlobeNewswire
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds - GlobeNewswire Inc.
Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha
GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World
GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register
Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register
Pre-market Movers: SXTC, STIM, BIOA, UPC... - RTTNews
GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire
GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan
GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan
GRI Bio files to sell 1.58M shares of common stock for holders - MSN
SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow
GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire
GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan
GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM
Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN
Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com
Primary Sclerosing Cholangitis Pipeline 2024: Clinical Trials - openPR
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India
GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio Announces Exercise of Warrants - GlobeNewswire
Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com
Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR
Energy storage ‘key’ to sustainability – report - Yahoo! Voices
As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices
2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices
Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices
Gri Bio Inc (GRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
5.38%
자본화:
|
볼륨(24시간):